EUVIMEDEUVIMED entdecken
Crossref

Beyond cortisol: multiplex steroid profiling after overnight dexamethasone suppression to optimize Cushing’s syndrome screening

Yumeng Gao, Danni Mu, Yichen Ma, Yuemeng Li, Ming Li, Yingying Hu, Ling Qiu, Songlin Yu, Xinqi Cheng

Endocrine · 2025

DOI: 10.1007/s12020-025-04480-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, 2025. Verfasst von Yumeng Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing,…. Hauptthemen laut MEDLINE: Cushing Syndrome, Dexamethasone, Hydrocortisone. Die Arbeit nennt 36 Literaturangaben. Gefördert von: the Noncommunicable Chronic Diseases-National Science and Technology Major Project, the Beijing Natural Science Foundation, the National Key Technologies R&D Program provided by Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cushing’s syndrome (CS) is a life-threatening endocrine disorder challenging to diagnose. The 1 mg Dexamethasone Suppression Test (DST) is highly sensitive but limited by specificity. This study evaluated the diagnostic value of liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based post-DST serum steroid profiling in improving the discrimination between overt CS and non-CS conditions, providing enhanced diagnostic resolution for mild autonomous cortisol secretion (MACS). METHODS: We prospectively analyzed paired pre- and post-DST serum from 232 patients (79 CS, 76 MACS, 77 controls) using an LC-MS/MS steroid panel. Individual and comparative diagnostic performance were assessed by receiver operating characteristic (ROC) analysis (AUROC, sensitivity, specificity); optimal cut-offs were determined by Youden’s index. We compared pre- versus post-DST metrics and examined subgroup (adrenal CS vs. pituitary CS) patterns. RESULTS: Post-DST profiling materially improved discrimination of overt CS. The six key analytes—cortisol (F), cortisone (E), 11-deoxycortisol (11-DF), 11β-hydroxytestosterone (11β-OHT), corticosterone (CORT), and 18-hydroxycorticosterone (18-OHF)—each showed strong diagnostic performance, with most AUROCs ≥ 0.90. A multivariable logistic model integrating these six post-DST markers achieved similarly high AUROCs (≥ 0.90) across all primary comparisons. However, discrimination against MACS was attenuated, and the panel did not reliably distinguish pituitary from adrenal etiologies. CONCLUSIONS: LC-MS/MS-based multi-hormone analysis of post-DST serum substantially enhances DST diagnostic accuracy for overt CS compared with baseline measures. Multi-hormone dynamics mitigate single F assessment limitations, offering a novel approach for diagnostic optimization and subclassification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cushing SyndromeDexamethasoneHydrocortisoneHumansFemaleMaleTandem Mass SpectrometryMiddle AgedAdultProspective StudiesLiquid Chromatography-Mass SpectrometryChromatography, LiquidCortodoxoneCortisone

Stichwörter der Autor:innen

1 mg dexamethasone suppression testCushing’s syndromeDiagnostic biomarkerLC-MS/MSSerum steroid profiling

Substanzen

DexamethasoneHydrocortisoneCortodoxoneCortisone

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, PR China.
  • Department of Laboratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, PR China. qiul@pumch.cn.
  • State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, PR China. qiul@pumch.cn.
  • Department of Laboratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, PR China. yusonglin@pumch.cn.
  • Department of Laboratory Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, 100730, PR China. chengxq@pumch.cn.

Förderung

  • the Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • the Beijing Natural Science Foundation
  • the National Key Technologies R&D Program provided by Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Gao, Y., Mu, D., Ma, Y., Li, Y., Li, M., Hu, Y., Qiu, L., Yu, S., & Cheng, X. (2025). Beyond cortisol: multiplex steroid profiling after overnight dexamethasone suppression to optimize Cushing’s syndrome screening. Endocrine. https://doi.org/10.1007/s12020-025-04480-9

Vancouver

Gao Y, Mu D, Ma Y, Li Y, Li M, Hu Y, et al. Beyond cortisol: multiplex steroid profiling after overnight dexamethasone suppression to optimize Cushing’s syndrome screening. Endocrine. 2025. doi:10.1007/s12020-025-04480-9

BibTeX
@article{Gao2025,
  author = {Gao, Yumeng and Mu, Danni and Ma, Yichen and Li, Yuemeng and Li, Ming and Hu, Yingying and Qiu, Ling and Yu, Songlin and Cheng, Xinqi},
  title = {Beyond cortisol: multiplex steroid profiling after overnight dexamethasone suppression to optimize Cushing’s syndrome screening},
  journal = {Endocrine},
  year = {2025},
  doi = {10.1007/s12020-025-04480-9}
}
Kostenlos starten →